A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Clinical trial NCT07446400 · RECRUITING
Trial details
- NCT number
- NCT07446400
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-31
- Primary completion
- 2026-11-07
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.